152 related articles for article (PubMed ID: 30956052)
1. Radiobiological dose calculation parameters for cervix cancer brachytherapy: A systematic review.
Chow B; Warkentin B; Menon G
Brachytherapy; 2019; 18(4):546-558. PubMed ID: 30956052
[TBL] [Abstract][Full Text] [Related]
2. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological treatment planning evaluation of inverse planning simulated annealing for cervical cancer high-dose-rate brachytherapy.
Palmqvist T; Dos S Matias L; Marthinsen AB; Sundset M; Wanderås AD; Danielsen S; Toma-Dasu I
Anticancer Res; 2015 Feb; 35(2):935-9. PubMed ID: 25667477
[TBL] [Abstract][Full Text] [Related]
4. BAIRDA: a novel
Chow B; Warkentin B; Nanda K; Ghosh S; Huang F; Gamper AM; Menon G
Phys Med Biol; 2022 Feb; 67(4):. PubMed ID: 35086068
[No Abstract] [Full Text] [Related]
5. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
6. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and Radiobiological Evaluation of Hybrid Inverse Planning and Optimization for Cervical Cancer Brachytherapy.
Matias Ldos S; Palmqvist T; Wolke J; Nilsson J; Beskow C; Maphossa AM; Toma-Dasu I
Anticancer Res; 2015 Nov; 35(11):6091-6. PubMed ID: 26504034
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer.
Dayyani M; Hoseinian-Azghadi E; Miri-Hakimabad H; Rafat-Motavalli L; Abdollahi S; Mohammadi N
Med Phys; 2021 Oct; 48(10):6213-6225. PubMed ID: 34415623
[TBL] [Abstract][Full Text] [Related]
12. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
14. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
[TBL] [Abstract][Full Text] [Related]
15. Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisation.
Bianchi C; Botta F; Conte L; Vanoli P; Cerizza L
Radiol Med; 2008 Oct; 113(7):1068-78. PubMed ID: 18618074
[TBL] [Abstract][Full Text] [Related]
16. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
17. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
18. Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix.
Fowler JF
Radiother Oncol; 1997 Oct; 45(1):49-54. PubMed ID: 9364631
[TBL] [Abstract][Full Text] [Related]
19. [Radiobiology in brachytherapy].
Hennequin C; Mazeron JJ
Cancer Radiother; 2013 Apr; 17(2):81-4. PubMed ID: 23562380
[TBL] [Abstract][Full Text] [Related]
20. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
